Sino Biopharmaceutical Limited

SBMFF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$9,570$9,452$8,655$9,600
Short-Term Investments$5,028$1,553$8,267$6,195
Receivables$5,013$4,596$4,643$4,285
Inventory$2,373$1,993$2,329$1,938
Other Curr. Assets$2,702$3,098$2,041$1,486
Total Curr. Assets$24,685$23,806$25,935$23,503
Property Plant & Equip (Net)$10,288$9,912$9,251$8,516
Goodwill$916$680$663$648
Intangibles$2,145$248$1,252$1,064
Long-Term Investments$26,337$25,181$16,963$18,975
Tax Assets$0$0$505$335
Other NC Assets$1,037$3,777$9,496$7,502
Total NC Assets$40,723$39,799$38,129$37,040
Other Assets$0$0$0$0
Total Assets$65,408$63,605$64,064$60,543
Liabilities
Payables$1,497$1,335$1,884$1,795
Short-Term Debt$7,704$11,207$9,724$6,585
Tax Payable$0$516$331$344
Deferred Revenue$0$0$0$0
Other Curr. Liab.$10,355$9,549$8,212$6,622
Total Curr. Liab.$19,556$22,607$20,151$15,345
LT Debt$2,080$1,373$4,258$5,532
Deferred Rev, NC$0$548$749$674
Deferred Tax Liab, NC$0$782$832$882
Other NC Liab.$997$125$131$381
Total NC Liab.$3,078$2,828$5,970$7,469
Other Liabilities$0$0$0$0
Cap. Leases$112$370$385$384
Total Liabilities$22,634$25,435$26,121$22,814
Equity
Pref Stock$0$5,686$10,078$0
Common Stock$414$415$415$415
Retained Earnings$25,281$23,649$23,070$27,215
AOCI$0-$9,949-$10,078-$9,228
Other Equity$6,266$10,673$6,285$11,889
Total Equity$31,961$30,474$29,747$30,291
Supplemental Information
Minority Interest$10,813$7,695$8,197$7,438
Total Liab. & Tot. Equity$65,408$63,605$64,064$60,543
Net Debt$214$3,128$5,327$2,518